Bengaluru, India

A Kasim Mookhtiar

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: A Kasim Mookhtiar. Retrieved from https://idiyas.com/inventor/a-kasim-mookhtiar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: A Kasim Mookhtiar: Innovator in Glucokinase Activation

Introduction

A Kasim Mookhtiar is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the area of glucokinase activation. His innovative work has the potential to impact the management and treatment of various medical conditions.

Latest Patents

Mookhtiar holds a patent for "Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application." This patent discloses pyrrole-2-carboxamide derivatives, including their polymorphs, stereoisomers, prodrugs, solvates, pharmaceutically acceptable salts, and formulations. These compounds are beneficial for the prophylaxis, management, treatment, control of progression, or adjunct treatment of diseases and medical conditions where the activation of glucokinase would be advantageous. The patent also outlines the process for preparing these pyrrole-2-carboxamides.

Career Highlights

Throughout his career, Mookhtiar has worked with various organizations, including Advinus Therapeutics Private Limited. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Mookhtiar has collaborated with notable professionals in his field, including Debnath Bhuniya and S. Gobind Kapkoti. These collaborations have further enhanced his research and development efforts.

Conclusion

A Kasim Mookhtiar's contributions to glucokinase activation represent a significant advancement in pharmaceutical innovation. His work continues to pave the way for new treatments and therapies that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…